Teams are getting leaner and flatter, while leaders at the top are overseeing more than ever before. Everyone, everywhere is ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The ...

Recent CDC data show that that wastewater SARS-CoV-2 detections are high and that LP.8.1 and related strains XFG and NB.1.8.1 ...

The World Health Organisation claims their roll-out prevented 14.4 million deaths worldwide in their first year, with some ...

In a major development, AHIP (formerly America's Health Insurance Plans), the insurance company trade group, announced that ...

Lilly claimed success in a head-to-head trial of oral GLP-1 drugs. Elsewhere, Novo planned a new weight loss trial and an AI-focused startup raised its second ‘megaround.’ ...

U.S. health insurers represented by America’s Health Insurance Plans pledge to cover CDC-recommended COVID and flu vaccines ...

Four Democratic-led Western states announced joint recommendations Wednesday about who should be vaccinated for seasonal ...

Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the ...

With confusion about eligibility for COVID-19 vaccines, Gov. Gretchen Whitmer is expected to sign an executive directive ...

Preliminary results from an ongoing Phase IV trial showed that Moderna’s updated 2025-2026 Spikevax vaccine generated a ...